Oscar Health, Inc. (NYSE:OSCR) is Ancient Art L.P.'s 5th Largest Position

Ancient Art L.P. lifted its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 66.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,950,753 shares of the company's stock after purchasing an additional 1,182,134 shares during the quarter. Oscar Health accounts for approximately 8.4% of Ancient Art L.P.'s investment portfolio, making the stock its 5th biggest holding. Ancient Art L.P. owned 1.19% of Oscar Health worth $39,658,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Lingotto Investment Management LLP bought a new position in shares of Oscar Health during the 4th quarter valued at approximately $2,543,000. GDS Wealth Management lifted its stake in Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after buying an additional 324,798 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Oscar Health by 296.0% during the fourth quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock valued at $3,105,000 after purchasing an additional 172,706 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Oscar Health during the fourth quarter valued at $5,672,000. Finally, Nordea Investment Management AB acquired a new position in shares of Oscar Health in the fourth quarter worth about $1,056,000. Institutional investors own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health presently has a consensus rating of "Hold" and a consensus target price of $20.21.

Oscar Health Price Performance

Shares of NYSE:OSCR traded up $0.24 during trading on Thursday, hitting $17.26. 9,219,901 shares of the company's stock were exchanged, compared to its average volume of 4,037,306. The company has a market cap of $4.32 billion, a price-to-earnings ratio of -862.57 and a beta of 1.75. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The business's 50-day simple moving average is $13.27 and its 200 day simple moving average is $14.62.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter in the prior year, the firm earned $0.62 EPS. Oscar Health's quarterly revenue was up 42.2% on a year-over-year basis. As a group, equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.